Brucellosis Vaccines Market 2027 By Product, Application, End User and Geography | The Insight Partners

Brucellosis Vaccines Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product (DNA Vaccines, Subunit Vaccines, Vector Vaccines, B. Abortus Recombinant Mutants, Others); Application (Cattle, Sheep, Pigs, Others); End User (Veterinary Hospitals, Veterinary Clinics, Animal Care Centers) and Geography

Report Code: TIPRE00008665 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Brucellosis is a notably transmissible zoonotic infection. Bacterial genus Brucella is accountable for the disease. Brucella is transported from animals to people by consumption of infected undercooked meat, foodstuff, or unpasteurized milk from infected animals. Immediate contact with an infected animal or their releases; or breathing of aerosols.

MARKET DYNAMICS

The brucellosis vaccines market is projected to grow in the forecast period owing to technological innovations, rising awareness about animal health. Moreover, the increasing funding by government organizations and associations, upsurge in demand for fish, milk, eggs, and animal protein and increased expenditure on health care of companion animals are also offering opportunities in market growth during the forecast period.

MARKET SCOPE

The "Global Brucellosis Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Brucellosis vaccines market with detailed market segmentation by product, application, end user and geography. The global brucellosis vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Brucellosis vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global brucellosis vaccines market is segmented on the basis of product, application, and end user. Based on type, the market is segmented into DNA vaccines, subunit vaccines, vector vaccines, B. abortus recombinant mutants, and others. Based on application, the brucellosis vaccines market is segmented into cattle, sheep, pigs, and others. Based on end user, the brucellosis vaccines market is segmented into veterinary hospitals, veterinary clinics, and animal care centers.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Brucellosis vaccines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Brucellosis vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting brucellosis vaccines market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Brucellosis vaccines market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the brucellosis vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from brucellosis vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for Brucellosis vaccines in the global market. Below mentioned is the list of few companies engaged in the Brucellosis vaccines market.

The report also includes the profiles of key brucellosis vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Boehringer Ingelheim
- Merck Animal Health
- Bayer AG
- Ceva
- CZ VACCINES
- Zoetis
- Biogénesis Bago
- Indian Immunologicals Limited
- Elanco (Lohmann Animal Health)
- Heska Corporation

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Brucellosis Vaccines Market - By Product
1.3.2 Brucellosis Vaccines Market - By Application
1.3.3 Brucellosis Vaccines Market - By End User
1.3.4 Brucellosis Vaccines Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. BRUCELLOSIS VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. BRUCELLOSIS VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. BRUCELLOSIS VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. BRUCELLOSIS VACCINES - GLOBAL MARKET OVERVIEW
6.2. BRUCELLOSIS VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. BRUCELLOSIS VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. DNA VACCINES
7.3.1. Overview
7.3.2. DNA Vaccines Market Forecast and Analysis
7.4. SUBUNIT VACCINES
7.4.1. Overview
7.4.2. Subunit Vaccines Market Forecast and Analysis
7.5. VECTOR VACCINES
7.5.1. Overview
7.5.2. Vector Vaccines Market Forecast and Analysis
7.6. B. ABORTUS RECOMBINANT MUTANTS
7.6.1. Overview
7.6.2. B. Abortus Recombinant Mutants Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. BRUCELLOSIS VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CATTLE
8.3.1. Overview
8.3.2. Cattle Market Forecast and Analysis
8.4. SHEEP
8.4.1. Overview
8.4.2. Sheep Market Forecast and Analysis
8.5. PIGS
8.5.1. Overview
8.5.2. Pigs Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. BRUCELLOSIS VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. VETERINARY HOSPITALS
9.3.1. Overview
9.3.2. Veterinary Hospitals Market Forecast and Analysis
9.4. VETERINARY CLINICS
9.4.1. Overview
9.4.2. Veterinary Clinics Market Forecast and Analysis
9.5. ANIMAL CARE CENTERS
9.5.1. Overview
9.5.2. Animal Care Centers Market Forecast and Analysis
10. BRUCELLOSIS VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Brucellosis Vaccines Market Overview
10.1.2 North America Brucellosis Vaccines Market Forecasts and Analysis
10.1.3 North America Brucellosis Vaccines Market Forecasts and Analysis - By Product
10.1.4 North America Brucellosis Vaccines Market Forecasts and Analysis - By Application
10.1.5 North America Brucellosis Vaccines Market Forecasts and Analysis - By End User
10.1.6 North America Brucellosis Vaccines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Brucellosis Vaccines Market
10.1.6.1.1 United States Brucellosis Vaccines Market by Product
10.1.6.1.2 United States Brucellosis Vaccines Market by Application
10.1.6.1.3 United States Brucellosis Vaccines Market by End User
10.1.6.2 Canada Brucellosis Vaccines Market
10.1.6.2.1 Canada Brucellosis Vaccines Market by Product
10.1.6.2.2 Canada Brucellosis Vaccines Market by Application
10.1.6.2.3 Canada Brucellosis Vaccines Market by End User
10.1.6.3 Mexico Brucellosis Vaccines Market
10.1.6.3.1 Mexico Brucellosis Vaccines Market by Product
10.1.6.3.2 Mexico Brucellosis Vaccines Market by Application
10.1.6.3.3 Mexico Brucellosis Vaccines Market by End User
10.2. EUROPE
10.2.1 Europe Brucellosis Vaccines Market Overview
10.2.2 Europe Brucellosis Vaccines Market Forecasts and Analysis
10.2.3 Europe Brucellosis Vaccines Market Forecasts and Analysis - By Product
10.2.4 Europe Brucellosis Vaccines Market Forecasts and Analysis - By Application
10.2.5 Europe Brucellosis Vaccines Market Forecasts and Analysis - By End User
10.2.6 Europe Brucellosis Vaccines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Brucellosis Vaccines Market
10.2.6.1.1 Germany Brucellosis Vaccines Market by Product
10.2.6.1.2 Germany Brucellosis Vaccines Market by Application
10.2.6.1.3 Germany Brucellosis Vaccines Market by End User
10.2.6.2 France Brucellosis Vaccines Market
10.2.6.2.1 France Brucellosis Vaccines Market by Product
10.2.6.2.2 France Brucellosis Vaccines Market by Application
10.2.6.2.3 France Brucellosis Vaccines Market by End User
10.2.6.3 Italy Brucellosis Vaccines Market
10.2.6.3.1 Italy Brucellosis Vaccines Market by Product
10.2.6.3.2 Italy Brucellosis Vaccines Market by Application
10.2.6.3.3 Italy Brucellosis Vaccines Market by End User
10.2.6.4 Spain Brucellosis Vaccines Market
10.2.6.4.1 Spain Brucellosis Vaccines Market by Product
10.2.6.4.2 Spain Brucellosis Vaccines Market by Application
10.2.6.4.3 Spain Brucellosis Vaccines Market by End User
10.2.6.5 United Kingdom Brucellosis Vaccines Market
10.2.6.5.1 United Kingdom Brucellosis Vaccines Market by Product
10.2.6.5.2 United Kingdom Brucellosis Vaccines Market by Application
10.2.6.5.3 United Kingdom Brucellosis Vaccines Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Brucellosis Vaccines Market Overview
10.3.2 Asia-Pacific Brucellosis Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific Brucellosis Vaccines Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Brucellosis Vaccines Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Brucellosis Vaccines Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Brucellosis Vaccines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Brucellosis Vaccines Market
10.3.6.1.1 Australia Brucellosis Vaccines Market by Product
10.3.6.1.2 Australia Brucellosis Vaccines Market by Application
10.3.6.1.3 Australia Brucellosis Vaccines Market by End User
10.3.6.2 China Brucellosis Vaccines Market
10.3.6.2.1 China Brucellosis Vaccines Market by Product
10.3.6.2.2 China Brucellosis Vaccines Market by Application
10.3.6.2.3 China Brucellosis Vaccines Market by End User
10.3.6.3 India Brucellosis Vaccines Market
10.3.6.3.1 India Brucellosis Vaccines Market by Product
10.3.6.3.2 India Brucellosis Vaccines Market by Application
10.3.6.3.3 India Brucellosis Vaccines Market by End User
10.3.6.4 Japan Brucellosis Vaccines Market
10.3.6.4.1 Japan Brucellosis Vaccines Market by Product
10.3.6.4.2 Japan Brucellosis Vaccines Market by Application
10.3.6.4.3 Japan Brucellosis Vaccines Market by End User
10.3.6.5 South Korea Brucellosis Vaccines Market
10.3.6.5.1 South Korea Brucellosis Vaccines Market by Product
10.3.6.5.2 South Korea Brucellosis Vaccines Market by Application
10.3.6.5.3 South Korea Brucellosis Vaccines Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Brucellosis Vaccines Market Overview
10.4.2 Middle East and Africa Brucellosis Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa Brucellosis Vaccines Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Brucellosis Vaccines Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Brucellosis Vaccines Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Brucellosis Vaccines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Brucellosis Vaccines Market
10.4.6.1.1 South Africa Brucellosis Vaccines Market by Product
10.4.6.1.2 South Africa Brucellosis Vaccines Market by Application
10.4.6.1.3 South Africa Brucellosis Vaccines Market by End User
10.4.6.2 Saudi Arabia Brucellosis Vaccines Market
10.4.6.2.1 Saudi Arabia Brucellosis Vaccines Market by Product
10.4.6.2.2 Saudi Arabia Brucellosis Vaccines Market by Application
10.4.6.2.3 Saudi Arabia Brucellosis Vaccines Market by End User
10.4.6.3 U.A.E Brucellosis Vaccines Market
10.4.6.3.1 U.A.E Brucellosis Vaccines Market by Product
10.4.6.3.2 U.A.E Brucellosis Vaccines Market by Application
10.4.6.3.3 U.A.E Brucellosis Vaccines Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Brucellosis Vaccines Market Overview
10.5.2 South and Central America Brucellosis Vaccines Market Forecasts and Analysis
10.5.3 South and Central America Brucellosis Vaccines Market Forecasts and Analysis - By Product
10.5.4 South and Central America Brucellosis Vaccines Market Forecasts and Analysis - By Application
10.5.5 South and Central America Brucellosis Vaccines Market Forecasts and Analysis - By End User
10.5.6 South and Central America Brucellosis Vaccines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Brucellosis Vaccines Market
10.5.6.1.1 Brazil Brucellosis Vaccines Market by Product
10.5.6.1.2 Brazil Brucellosis Vaccines Market by Application
10.5.6.1.3 Brazil Brucellosis Vaccines Market by End User
10.5.6.2 Argentina Brucellosis Vaccines Market
10.5.6.2.1 Argentina Brucellosis Vaccines Market by Product
10.5.6.2.2 Argentina Brucellosis Vaccines Market by Application
10.5.6.2.3 Argentina Brucellosis Vaccines Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BRUCELLOSIS VACCINES MARKET, KEY COMPANY PROFILES
12.1. BOEHRINGER INGELHEIM
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MERCK ANIMAL HEALTH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BAYER AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CEVA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CZ VACCINES
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ZOETIS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BIOGéNESIS BAGO
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. INDIAN IMMUNOLOGICALS LIMITED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ELANCO (LOHMANN ANIMAL HEALTH)
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. HESKA CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Boehringer Ingelheim
2. Merck Animal Health
3. Bayer AG
4. Ceva
5. CZ VACCINES
6. Zoetis
7. Biogénesis Bago
8. Indian Immunologicals Limited
9. Elanco (Lohmann Animal Health)
10. Heska Corporation
TIPRE00008665
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking